Abeona Therapeutics (ABEO) Announces Clinical Update on MPS IIIA Gene Therapy Trial
Tweet Send to a Friend
Abeona Therapeutics Inc. (NASDAQ: ABEO) announced today updated clinical data from the Phase 1/2 trial for ABO-102 (AAV-SGSH), the company’s ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
